Issue 5/2015
Content (7 Articles)
Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira)
Javier Morales, Ludwig Merker
Absence of Drug–Drug Interactions Between Luseogliflozin, a Sodium–Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males
Takashi Sasaki, Yutaka Seino, Atsushi Fukatsu, Michito Ubukata, Soichi Sakai, Yoshishige Samukawa
Evaluation of the Safety Profile of Zolafren®, a Generic Olanzapine Formulation, in Patients with Bipolar Disorder: A Post-Authorization Safety Study
Jerzy Chudek, Magdalena Olszanecka-Glinianowicz, Agnieszka Almgren-Rachtan, Tomasz Gabryelewicz
Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study
Roger S. McIntyre, Emmanuelle Weiller
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
Ali-Frédéric Ben-Amor, Anton Trochanov, Tanya Z. Fischer
Cost–Utility of First-Line Actinic Keratosis Treatments in Finland
Erkki J. Soini, Taru Hallinen, Anna-Leena Sokka, Kari Saarinen
Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
Adeyinka Abinusawa, Srini Tenjarla